The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases

References

• Starley BQ , Calcagno CJ , Harrison SA . Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology . 2010;51(5):1820–1832. doi:10.1002/hep.23594 20432259
   PubMed Web of Science ®Google Scholar
• Marra F , Gastaldelli A , Svegliati BG , Tell G , Tiribelli C . Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med . 2008;14(2):72–81. doi:10.1016/j.molmed.2007.12.003 18218340
   PubMed Web of Science ®Google Scholar
• Ferreira DM , Simao AL , Rodrigues CM , Castro RE . Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. FEBS J . 2014;281(11):2503–2524. doi:10.1111/febs.12806 24702768
   PubMed Web of Science ®Google Scholar
• Spengler EK , Loomba R . Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc . 2015;90(9):1233–1246. doi:10.1016/j.mayocp.2015.06.013 26219858
   PubMed Web of Science ®Google Scholar
• Myers RP , Pollett A , Kirsch R , et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int . 2012;32(6):902–910. doi:10.1111/liv.2012.32.issue-6 22435761
   PubMed Web of Science ®Google Scholar
• Shen F , Zheng RD , Mi YQ , et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol . 2014;20(16):4702–4711. doi:10.3748/wjg.v20.i16.4702 24782622
   PubMed Web of Science ®Google Scholar
• Ma H , Wu Y , Yang H , et al. MicroRNAs in oral lichen planus and potential mi-RNA-mRNA pathogenesis with essential cytokines: a review. Oral Surg Oral Med Oral Pathol Oral Radiol . 2016;122(2):164–173. doi:10.1016/j.oooo.2016.03.018 27282956
   PubMed Web of Science ®Google Scholar
• Mehta R , Otgonsuren M , Younoszai Z , Allawi H , Raybuck B , Younossi Z . Circulating mi-RNA in patients with non-alcoholic fatty liver disease and coronary artery disease. BMJ Open Gastroenterol . 2016;3(1):e000096. doi:10.1136/bmjgast-2016-000096
   Google Scholar
• Selbach M , Schwanhausser B , Thierfelder N , Fang Z , Khanin R , Rajewsky N . Widespread changes in protein synthesis induced by microRNAs. Nature . 2008;455(7209):58–63. doi:10.1038/nature07228 18668040
   PubMed Web of Science ®Google Scholar
• Ambros V . The functions of animal microRNAs. Nature . 2004;431(7006):350–355. doi:10.1038/nature02871 15372042
   PubMed Web of Science ®Google Scholar
• Lee RC , Ambros V . An extensive class of small RNAs in Caenorhabditiselegans. Science . 2001;294(5543):862–864. doi:10.1126/science.1065329 11679672
   PubMed Web of Science ®Google Scholar
• Pirola CJ , Fernandez GT , Castano GO , et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut . 2015;64(5):800–812. doi:10.1136/gutjnl-2014-306996 24973316
   PubMed Web of Science ®Google Scholar
• Weiland M , Gao XH , Zhou L , Mi QS . Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol . 2012;9(6):850–859. doi:10.4161/rna.20378 22699556
   PubMed Web of Science ®Google Scholar
• Kloosterman WP , Plasterk RH . The diverse functions of microRNAs in animal development and disease. Dev Cell . 2006;11(4):441–450. doi:10.1016/j.devcel.2006.09.009 17011485
   PubMed Web of Science ®Google Scholar
• Daimiel-Ruiz L , Klett-Mingo M , Konstantinidou V , et al. Dietary lipids modulate the expression of mi-RNA-107, a mi-RNA that regulates the circadian system. Mol Nutr Food Res . 2015;59(9):1865–1878.26387852
   PubMed Web of Science ®Google Scholar
• Srinivasan H , Das S . Mitochondrial mi-RNA (Mitomi-R): a new player in cardiovascular health. Can J Physiol Pharmacol . 2015;93(10):855–861. doi:10.1139/cjpp-2014-0500 26030833
   PubMed Web of Science ®Google Scholar
• Shaked A , Chang BL , Barnes MR , et al. An ectopically expressed serum mi-RNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Hepatology . 2017;65(1):269–280. doi:10.1002/hep.28786 27533743
   PubMed Web of Science ®Google Scholar
• Zhou X , Jeker LT , Fife BT , et al. Selective mi-RNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med . 2008;205(9):1983–1991. doi:10.1084/jem.20080707 18725525
   PubMed Web of Science ®Google Scholar
• Cramer DW , Elias KM . A prognostically relevant mi-RNA signature for epithelial ovarian cancer. Lancet Oncol . 2016;17(8):1032–1033. doi:10.1016/S1470-2045(16)30149-8 27402146
   PubMed Web of Science ®Google Scholar
• Mollainezhad H , Eskandari N , Pourazar A , Salehi M , Andalib A . Expression of microRNA-370 in human breast cancer compare with normal samples. Adv Biomed Res . 2016;5:129. doi:10.4103/2277-9175.186987 27563639
   PubMedGoogle Scholar
• Salvoza NC , Klinzing DC , Gopez-Cervantes J , Baclig MO . Association of circulating serum mi-RNA-34a and mi-RNA-122 with dyslipidemia among patients with non-alcoholic fatty liver disease. PLoS One . 2016;11(4):e0153497. doi:10.1371/journal.pone.0153497 27077736
   PubMed Web of Science ®Google Scholar
• Moore KJ , Rayner KJ , Suarez Y , Fernandez-Hernando C . The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr . 2011;31:49–63. doi:10.1146/annurev-nutr-081810-160756 21548778
   PubMed Web of Science ®Google Scholar
• Sacco J , Adeli K . MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol . 2012;23(3):220–225. doi:10.1097/MOL.0b013e3283534c9f 22488426
   PubMed Web of Science ®Google Scholar
• Gori M , Arciello M , Balsano C . MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int . 2014;2014:741465. doi:10.1155/2014/741465 24745023
   PubMed Web of Science ®Google Scholar
• Lee J , Padhye A , Sharma A , et al. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem . 2010;285(17):12604–12611. doi:10.1074/jbc.M109.094524 20185821
   PubMed Web of Science ®Google Scholar
• Min HK , Kapoor A , Fuchs M , et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab . 2012;15(5):665–674. doi:10.1016/j.cmet.2012.04.004 22560219
   PubMed Web of Science ®Google Scholar
• Castro RE , Ferreira DM , Afonso MB , et al. MiR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J Hepatol . 2013;58(1):119–125. doi:10.1016/j.jhep.2012.08.008 22902550
   PubMed Web of Science ®Google Scholar
• Li D , Liu X , Lin L , et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem . 2011;286(42):36677–36685. doi:10.1074/jbc.M111.270561 21878637
   PubMed Web of Science ®Google Scholar
• Kloting N , Berthold S , Kovacs P , et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One . 2009;4(3):e4699. doi:10.1371/journal.pone.0004699 19259271
   PubMed Web of Science ®Google Scholar
• Hyysalo J , Mannisto VT , Zhou Y , et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol . 2014;60(4):839–846. doi:10.1016/j.jhep.2013.12.009 24333862
   PubMed Web of Science ®Google Scholar
• Di-Stefano JK , Gerhard GS . Circulating microRNAs in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol . 2016;10(2):161–163. doi:10.1586/17474124.2016.1125290 26606259
   PubMed Web of Science ®Google Scholar
• Elbaz T , Abdo M , Omar H , et al. Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection. J Med Virol . 2019;91(2):272–277. doi:10.1002/jmv.25287.30138531
   PubMed Web of Science ®Google Scholar
• Omar N , Gamil K , Abdel-Samiee M , Naguib M . IP-10 as a predictor of treatment response in chronic hepatitis C patients. Int J Adv Res . 2017;5:752–766. doi:10.21474/IJAR01/3568
   Google Scholar
• El Samiee MA , Tharwa ES , Obada MA , Gabal AKA , Salama M . Gamma-glutamyltranspeptidase and α-fetoprotein: are they predictors of treatment response in patients with chronic hepatitis C? Egypt Liver J . 2011;1(1):18–24. doi:10.1097/01.ELX.0000397031.25671.75
   Google Scholar
• El-Shafie M , Allam H , El-Shall L , et al. Nuclear factor-kappa B expression and acyl-ghrelin in egyptian patients with non-alcoholic fatty liver. World J Res Rev . 2017;4(3):1–7.
   Google Scholar
• Jampoka K , Muangpaisarn P , Khongnomnan K , Treeprasertsuk S , Tangkijvanich P , Payungporn S . Serum mi-RNA-29a and mi-RNA-122 as potential biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD). Microrna . 2018;7(3):215–222. doi:10.2174/2211536607666180531093302 29848284
   PubMedGoogle Scholar
• Cermelli S , Ruggieri A , Marrero JA , Ioannou GN , Beretta L . Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One . 2011;6(8):e23937. doi:10.1371/journal.pone.0023937 21886843
   PubMed Web of Science ®Google Scholar
• Tryndyak VP , Latendresse JR , Montgomery B , et al. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet. Toxicol Appl Pharmacol . 2012;262(1):52–59. doi:10.1016/j.taap.2012.04.018 22561871
   PubMed Web of Science ®Google Scholar
• Yamada H , Suzuki K , Ichino N , et al. Associations between circulating microRNAs (mi-RNA-21, mi-RNA-34a, mi-RNA-122 and mi-RNA-451) and non-alcoholic fatty liver. Clin Chim Acta . 2013;424:99–103. doi:10.1016/j.cca.2013.05.021 23727030
   PubMed Web of Science ®Google Scholar
• Elmen J , Lindow M , Schutz S , et al. LNA-mediated microRNA silencing in non-human primates. Nature . 2008;452(7189):896–899. doi:10.1038/nature06783 18368051
   PubMed Web of Science ®Google Scholar
• Cheung O , Puri P , Eicken C , et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology . 2008;48(6):1810–1820. doi:10.1002/hep.22569 19030170
   PubMed Web of Science ®Google Scholar
• Celikbilek M , Baskol M , Taheri S , et al. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol . 2014;6(8):613–620. doi:10.4254/wjh.v6.i8.613 25232454
   PubMedGoogle Scholar
• Pogribny IP , Starlard-Davenport A , Tryndyak VP , et al. Difference in expression of hepatic microRNAs mi-RNA-29c, mi-RNA-34a, mi-RNA-155, and mi-RNA-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest . 2010;90(10):1437–1446. doi:10.1038/labinvest.2010.113 20548288
   PubMed Web of Science ®Google Scholar
• Estep M , Armistead D , Hossain N , et al. Differential expression of mi-RNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther . 2010;32(3):487–497. doi:10.1111/apt.2010.32.issue-3 20497147
   PubMed Web of Science ®Google Scholar
• Lopez-Riera M , Conde I , Quintas G , et al. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Sci Rep . 2018;8(1):10606. doi:10.1038/s41598-018-28854-4 30006517
   PubMed Web of Science ®Google Scholar
• Liu CH , Ampuero J , Gil-Gomez A , et al. mi-RNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol . 2018;69(6):1335–1348. doi:10.1016/j.jhep.2018.08.008 30142428
   PubMed Web of Science ®Google Scholar
• Akuta N , Kawamura Y , Suzuki F , et al. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Hepatol Int . 2016;10(4):647–656. doi:10.1007/s12072-016-9729-2 27074850
   PubMed Web of Science ®Google Scholar